These findings suggest that TPMs produce INSL6 and Jagged 1 to stimulate bone formation, and that anti-TNF Ab blocks not only enhanced bone resorption, but also the anabolic effect of TPMs on bone, limiting its ability to increase bone mass in this model of RA. Here, INSL6 is linked to rheumatoid arthritis.